期刊文献+

Lp(a)、apo B/apo A-1比值对AMI患者介入治疗后发生主要不良心血管事件的预测价值 被引量:6

Predictive values of Lp(a)and apoB/apoA-1 ratio for the occurrence of MACE in patients with AMI after interventional therapy
下载PDF
导出
摘要 目的探讨脂蛋白(a)[Lp(a)]、载脂蛋白B(apo B)/载脂蛋白A-1(apo A-1)比值对急性心肌梗死(AMI)患者介入治疗后发生主要不良心血管事件(MACE)的预测价值。方法选取行介入治疗的AMI患者200例,根据介入治疗后6个月是否发生MACE分为MACE组(47例)、无MACE组(153例)。收集所有患者的基本资料和入院时的实验室检测结果,同时检测Lp(a)、apo B、apo A-1水平。采用Pearson相关分析评估Lp(a)、apo B/apo A-1比值与氨基末端B型钠尿肽原(NT-proBNP)、左心室射血分数(LVEF)、低密度脂蛋白胆固醇(LDL-C)的相关性。采用Cox回归分析评估AMI患者介入治疗后发生MACE的影响因素。采用受试者工作特征(ROC)曲线评价Lp(a)、apo B/apo A-1比值判断MACE发生的效能。结果MACE组Lp(a)、apo B/apo A-1比值高于无MACE组(P<0.05)。Pearson相关分析结果显示,Lp(a)、apo B/apo A-1比值与NT-proBNP、LDL-C均呈正相关(P<0.05),与LVEF呈负相关(P<0.05)。Cox回归分析结果显示,Lp(a)、apo B/apo A-1比值是AMI介入治疗后发生MACE的影响因素[风险比(HR)分别为2.347、2.476,95%可信区间(CI)分别为1.459~3.774、1.561~3.928]。ROC曲线分析结果显示,Lp(a)、apo B/apo A-1比值单项检测和联合检测模型判断AMI患者介入治疗后发生MACE的曲线下面积(AUC)分别为0.798、0.821、0.898。结论Lp(a)、apoB/apo A-1比值升高是AMI患者介入治疗后发生MACE的危险因素,在AMI患者介入治疗的预后评估中有一定的临床意义。 Objective To investigate the predictive values of lipoprotein(a)[Lp(a)]and apolipoprotein B(apo B)/apolipoprotein A-1(apo A-1)ratio for the occurrence of major adverse cardiovascular event(MACE)in patients with acute myocardial infarction(AMI)after interventional therapy.Methods A total of 200 patients with AMI undergoing interventional therapy were enrolled.According to the occurrence of MACE for 6 months after interventional therapy,they were classified into MACE group(47 cases)and non-MACE group(153 cases).Baseline data and clinical laboratory results were collected,and Lp(a),apo B and apo A-1 were determined.Pearson correlation analysis was used to analyze the correlation between Lp(a),apo B/apo A-1 ratio and aminoterminal pro-B-type natriuretic peptide(NT-proBNP),left ventricular ejection fraction(LVEF)and low-density lipoprotein cholesterol(LDL-C).Cox regression analysis was used to analyze the influencing factors of MACE in AMI patients after interventional therapy.Receiver operating characteristic(ROC)curve analysis was used to evaluate the predictive value of Lp(a)and apo B/apo A-1 ratio combined determination for the occurrence of MACE after interventional therapy.Results Lp(a)and apo B/apo A-1 ratio in MACE group were higher than those in non-MACE group(P<0.05).The results of Pearson correlation analysis showed that Lp(a)and apo B/apo A-1 ratio were positively correlated with NT-proBNP and LDL-C(P<0.05),and they were negatively correlated with LVEF(P<0.05).Cox regression analysis showed that Lp(a)and apo B/apo A-1 ratio were the influencing factors of MACE[hazard ratios(HR)were 2.347 and 2.476,95%confidence intervals(CI)were 1.459-3.774 and 1.561-3.928,respectively].The results of ROC curve analysis showed that the areas under curves(AUC)of Lp(a),apo B/apo A-1 ratio single determinations and combined determination for the occurrence of MACE in AMI patients after interventional therapy were 0.798,0.821 and 0.898,respectively.Conclusions The high levels of Lp(a)and apo B/apo A-1 ratio are independent risk factors for MACE in AMI patients after interventional therapy.The combined determination has a high predictive value for the prognosis of interventional therapy in AMI patients.
作者 郑家华 姚艳影 高庆玲 董晔 ZHENG Jiahua;YAO Yanying;GAO Qingling;DONG Ye(Department of General Medicine,Chengde Central Hospital,Chengde 067000,Hebei,China)
出处 《检验医学》 CAS 2022年第12期1141-1145,共5页 Laboratory Medicine
基金 承德市科学技术局资助项目(202006A158)。
关键词 脂蛋白(a) 载脂蛋白B/载脂蛋白A-1比值 急性心肌梗死 主要不良心血管事件 Lipoprotein(a) Apolipoprotein B/apolipoprotein A-1 ratio Acute myocardial infarction Major adverse cardiovascular event
  • 相关文献

参考文献13

二级参考文献116

  • 1陈炎,庞文晶,周立波.m-AST与AST比值在冠心病、肝脏疾病患者病程中的变化及临床意义[J].宁夏医科大学学报,2013,35(11):1269-1271. 被引量:5
  • 2刘旭杰,张兴华.青年冠心病研究进展[J].心血管病学进展,2006,27(6):756-759. 被引量:12
  • 3Yan8 G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet, 2023; 381, 1987-2015.
  • 4Libby P. Inflammation in atherosclerosis. Nature, 2002; 420, 868-74.
  • 5Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med, 2009; 151, 483-95.
  • 6Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack The Framingham Study. Stroke, 2001; 32, 2575-9.
  • 7Luna JM, Moon YP, Liu KM, et al. High-Sensitivity C-Reac'dve Protein and Interleukin-6-Dominant Inflammation and Ischemic Stroke Risk The Northern Manhattan Study. Stroke, 2014; 45, 979-87.
  • 8Bos MJ, Schipper CM, Koudstaal PJ, et al. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation, 2006; 114, 1591-8.
  • 9Walldius G, Jungner I, Holme I, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet, 2001; 358, 2026-33.
  • 10Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med, 2004; 255, 188-205.

共引文献216

同被引文献64

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部